J. S. DIXON, P. R. WORTHINGTON, J. G. MILLS & J. R. WOOD. (2007) Geographical differences of gastric ulcer healing rate in patients treated with ranitidine or placebo. Alimentary Pharmacology & Therapeutics 3:4, pages 353-365.
Crossref
S. J. Konturek. 1988. Eicosanoids and the Gastrointestinal Tract. Eicosanoids and the Gastrointestinal Tract
46
74
.
B. M. Peskar. 1988. 94. Kongreß. 94. Kongreß
292
298
.
P. Demol. 1988. Prostaglandins and Leukotrienes in Gastrointestinal Diseases. Prostaglandins and Leukotrienes in Gastrointestinal Diseases
90
104
.
Dov Wengrower, Alexander Fich, Eran Goldin, Rami Eliakim, Moshe Ligumsky & Daniel Rachmilewitz. (1987) Cytoprotective doses of arbacet with minimal antisecretory properties are not effective in duodenal ulcer healing. Digestive Diseases and Sciences 32:8, pages 857-860.
Crossref
Donald E. Wilson. (1987) Antisecretory and mucosal protective actions of misoprostol. The American Journal of Medicine 83:1, pages 2-8.
Crossref
S. J. Konturek, N. Kwiecien, T. Radecki & J. Oleksy. 1987. Side-Effects of Anti-Inflammatory Drugs. Side-Effects of Anti-Inflammatory Drugs
123
132
.
S. K. LAM. (2008) Prostaglandins for duodenal ulcer and gastric ulcer. Journal of Gastroenterology and Hepatology 1:6, pages 471-481.
Crossref
Hanns-Gerd Dammann, Wolfram Hüttemann, Horst Dieter Kalek, Heinz Georg Rohner & Bernd Simon. (1986) Comparative clinical trial of enprostil and ranitidine in the treatment of gastric ulcer. The American Journal of Medicine 81:2, pages 80-84.
Crossref
Susumu OKABE, Hiroshi JINO & Akito NISHIDA. (1986) Effects of 15(R)-15-Methyl Prostaglandin E2 (Arbaprostil) on Gastric Secretion and Various Gastric Lesions Induced in Rats. Japanese Journal of Pharmacology 40:2, pages 329-337.
Crossref
H. J. Lenz, S. Brozinsky, M. A. Koss, D. L. Hogan, M. L. Scheinbaum & J. I. Isenberg. (1986) Effect of 11R, 16, 16-trimethyl prostaglandin E2 on meal-stimulated gastric acid secretion in duodenal ulcer subjects. European Journal of Clinical Pharmacology 31:3, pages 281-284.
Crossref
Jorge E. Valenzuela & Hartley Cohen. 1986. Topics in Clinical Pharmacology and Therapeutics. Topics in Clinical Pharmacology and Therapeutics
151
174
.
Norbert Charlet, Hugo E. Gallo‐Torres, Yves Bounameaux & Robert J. Wills. (2013) Prostaglandins and the Protection of the Gastroduodenal Mucosa in Humans: A Critical Review. The Journal of Clinical Pharmacology 25:8, pages 564-582.
Crossref
C.J. Hawkey & D.S. Rampton. (1985) Prostaglandins and the gastrointestinal mucosa: Are they important in its function, disease, or treatment?. Gastroenterology 89:5, pages 1162-1188.
Crossref
F. P. Brooks. (1985) The pathophysiology of peptic ulcer disease. Digestive Diseases and Sciences 30:S11, pages 15S-29S.
Crossref
A. Robert, P.A. Aristoff, M.G. Wendling, F.A. Kimball, W.J. MillerJr.Jr. & R.R. Gorman. (1985) Cytoprotective and antisecretory properties of a non-diarrheogenic and non-uterotonic prostacyclin analog: U-68, 215. Prostaglandins 30:4, pages 619-649.
Crossref
H. El-Bayer, L. Steel, E. Montcalm, E. Danquenchin-Dorval, A. Dubois & T. Shea-Donohue. (1985) The role of endogenous prostaglandins in the regulation of gastric secretion in rhesus monkeys. Prostaglandins 30:3, pages 401-417.
Crossref
Max M. Cohen, Lorenna Clark, Lynn Armstrong & Joseph D'Souza. (1985) Reduction of aspirin-induced fecal blood loss with low-dose misoprostol tablets in man. Digestive Diseases and Sciences 30:7, pages 605-611.
Crossref
D. Lee & D. Dvornik. (1985) Etodolac: Effect on prostaglandin concentrations in gastric mucosa of rats. Life Sciences 36:12, pages 1157-1162.
Crossref
Andrzej Tarnawski. (1985) Prevention and treatment of gastrointestinal mucosal injury with cytoprotective agents. Medical Journal of Australia 142:S3.
Crossref
G. N. J. Tijtgat. 1985. Peptic Ulcer Disease: Basic and Clinical Aspects. Peptic Ulcer Disease: Basic and Clinical Aspects
143
153
.
S.J. Konturek, T. Brzozowski, T. Radecki & I. Pastucki. (1984) Comparison of gastric and intestinal antisecretory and protective effects of prostacyclin and its stable thia-amino-analogue (HOE 892) in consious rats. Prostaglandins 28:4, pages 443-453.
Crossref
Donald E. Wilson, M.D. Hulya Levendoglu, M.D. Andrea Adams & Elaine Ramsamooj. (1984) A new PGE1 analogue (CL115,574) III. Effects on gastric acid and mucus secretion in man. Prostaglandins 28:1, pages 5-11.
Crossref
S. J. Konturek. 1984. IUPHAR 9th International Congress of Pharmacology London 1984. IUPHAR 9th International Congress of Pharmacology London 1984
341
344
.
Max M. Cohen. (1983) Diflunisal protects human gastric mucosa against damage by indomethacin. Digestive Diseases and Sciences 28:12, pages 1070-1077.
Crossref
S.S. Kerwar. (1983) Pharmacologic properties of fenbufen. The American Journal of Medicine 75:4, pages 62-69.
Crossref
B. Kollberg & P. Slezak. (1982) The effect of prostaglandin E2 on duodenal ulcer healing. Prostaglandins 24:4, pages 527-536.
Crossref
J. Silvola, M. Kangasaho, O. Tokola & H. Vapaatalo. (1982) Effects of nonsteroidal anti-inflammatory drugs on rat gastric mucosal phosphodiesterase activity. Agents and Actions 12:4, pages 516-520.
Crossref
Harvey H. Sigman & Anton Gillich. (1982) Effects of antacids, cimetidine, and 16, 16-dimethyl prostaglandin E2 on acute gastric erosions in a spinal rat. Digestive Diseases and Sciences 27:3, pages 220-224.
Crossref
John P. Wright, Gerry O. Young, Leslie J. Klaff, Lorraine A. Weers, Stephen K. Price & I.N. Marks. (1982) Gastric mucosal prostaglandin E levels in patients with gastric ulcer disease and carcinoma. Gastroenterology 82:2, pages 263-267.
Crossref
O. Oelz. 1982. Ergebnisse der Inneren Medizin und Kinderheilkunde / Advances in Internal Medicine and Pediatrics. Ergebnisse der Inneren Medizin und Kinderheilkunde / Advances in Internal Medicine and Pediatrics
105
144
.
W.-P. Fritsch. 1982. Ulcus-Therapie. Ulcus-Therapie
300
324
.
S. A. Müller-Lissner, F. Pace, H. F. Weiser, J. R. Siewert, A. L. Blum, E. Erckenbrecht, W. Berges, J. Erckenbrecht, M. Wienbeck, T. Sauerbruch, R. Wirsching, B. Leisner, M. Weinzierl, M. Pfahler, G. Paumgartner, P.-H. Althoff, A. Hellstern, G. Wöhrle, M. Classen, R.-D. Hanrath, W.-P. Fritsch, T. Scholten, J. E. Müller, G. Strohmeyer, J. Caspari, S. Domschke, A. Dembiński, W. Domschke, H. G. Dammann, P. Müller, B. Simon, A. Sonnenberg, C. West, S. Panzer, S. Meryn, H. Lochs, P. Nowotny, P. Herzog, B. Ebener, K. H. Holtermüller, W. Rösch, J. Schaudi, K. Elster, B. Lembcke, U. R. Fölsch, W. F. Caspary, W. Creutzfeldt, M. M. Körner, H. Heckers, F. W. Melcher, F. W. Schmahl, H.-P. Buscher, H. Sauerbier, W. Kramer, G. Kurz, W. Gerok, F. Stellaard, C. Brunhölzl, W. E. Hansen, H. Maurer, H. Haberland, J. Vollmar, C. Bräuning, S. Matern, A. Schill, R. Ritz, W. Lehnert, H. Matern, R. Raedsch, A. Stiehl, P. Czygan, S. Walker, B. Kommerell, K. Kutz, O. Leiss, K. Bergmann, J. Dlugosz, M. V. Singer, V. Eyßelein, H. Wentz, H. Goebell, J. Lohse, R. Krämer, M. Dörner, K. Wurster, H. Kaess, C. Niederau, V. Häger, H. Weiss, W. Sommer, A. Weiss, R. Rethel, W. Keller, H. Malchow, K. Ewe, J. W. Brandes, H. Ehms, H. J. Jesdinsky, U. Karbach, P. Schramm, C. Bossaller, O. Schober, W. Wellmann, L. Lehr, J. Schölmerich, M.-S. Becher, E. Köttgen, P. Hoppe-Seyler, E. Löhle, J. P. Vuilleumier, B. M. Peskar, H. Weiler, E. E. Kröner, W. Kruis, J. Holl, W. Paulus & P. Schüßler. 1982. Verhandlungen der Deutschen Gesellschaft für innere Medizin. Verhandlungen der Deutschen Gesellschaft für innere Medizin
513
605
.
A Robert, G Kane & S B Reele. (1981) Dose response inhibition in man of meal-stimulated gastric acid secretion by 15(R)-15-methyl prostaglandin E2, given orally.. Gut 22:9, pages 728-731.
Crossref
Donald E. Wilson & Hulya Kaymakcalan. (1981) Prostaglandins: Gastrointestinal Effects and Peptic Ulcer Disease. Medical Clinics of North America 65:4, pages 773-787.
Crossref
C. Johansson & B. Kollberg. (1981) Clinical trials with prostaglandin E2. Prostaglandins 21, pages 161-164.
Crossref
Andrew F. Ippoliti, Jon I. Isenberg & Linda Hagie. (1981) Effect of oral and intravenous 16,16-dimethyl prostaglandin E2 in duodenal ulcer and Zollinger-Ellison syndrome patients. Gastroenterology 80:1, pages 55-59.
Crossref
W. Berges, T. Stolze, M. Wienbeck, G. Lux, J. Femppel, P. C. Lederer, W. Domschke, W. Rösch, H. Kasper, C. Reiners, C. Eilles, W. Börner, H. K. Seitz, P. Czygan, H. Kienapfel, B. Kommerell, W. Rösch, A. Sonnenberg, D. Stucke, N. Hüsmert, S. A. Müller-Lissner, A. L. Blum, K.-H. Holtermüller, P. Herzog, R. Arnold, M. Rothmund, W. Seitz, P. John, H. Ruppin, C. Hartog, S. Domschke, J. Reimann, J. Ring, P. Wendt, R. Lorenz, B. Ultsch, K. Swoboda, G. Blümel, S. E. Miederer, M. Becker, P. Müller, N. Fischer, H. Kather, B. Simon, B. M. Peskar, K. Rainsford, K. Brune, W. Gerok, A. Springer, M. Pfreundschuh, G. E. Feurle, J. D. Beck, U. Karbach, K. Ewe, H. Bodenstein, M. U. Schneider, J. F. Riemann, S. Strobel, L. Demling, K. J. Goerg, K. H. Soergel, R. Wanitschke, C. M. Wood, F. Kluge, H. Grosse-Wilde, K. Krumbacher, H. Schmidt, K. H. Holtermüller, P. Frühmorgen, H.-P. Buscher, H. Abberger, K. Fuchte, G. Kurz, G. Bandomer, F. Begemann, W. Krüger, V. Schumpelick, R. Raedsch, A. Stiehl, R. Götz, S. Walker, R. Götz, H. Seitz, E. Weber, U. M. Farack, G. Nell & O. Lueg. 1981. Verhandlungen der Deutschen Gesellschaft für innere Medizin. Verhandlungen der Deutschen Gesellschaft für innere Medizin
802
877
.
André Robert. 1981. The Prostaglandin System. The Prostaglandin System
393
400
.
J. W. Harting. (1980) Prostaglandines en het maag-darmkanaal. Pharmaceutisch Weekblad Scientific Edition 2:1, pages 660-664.
Crossref
H. Ruppin, B. Person, W. Domschke & A. Robert. 1980. Verhandlungen der Deutschen Gesellschaft für innere Medizin. Verhandlungen der Deutschen Gesellschaft für innere Medizin
873
875
.
André Robert. (1979) Cytoprotection by prostaglandins. Gastroenterology 77:4, pages 761-767.
Crossref
E.R.H. Walker. 1979. Chemistry, Biochemistry, and Pharmacological Activity of Prostanoids. Chemistry, Biochemistry, and Pharmacological Activity of Prostanoids
326
345
.
A. Robert. 1979. Practical Applications of Prostaglandins and their Synthesis Inhibitors. Practical Applications of Prostaglandins and their Synthesis Inhibitors
89
102
.